Die europäischen Leitlinien zur Versorgung von Gefäßprothesen- und Stentgraftinfektionen

Diener, Holger; Chakfé, Nabil; Honig, Susanne

doi:10.1007/s00772-020-00712-6

Cited by 2 publications

(1 citation statement)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Systemic antibiotics alone are not sufficient but are nevertheless necessary as concomitant therapy. Initially, if the pathogen is unknown, broad-spectrum antibiotics should be used, and then a pathogen-specific adjustment should be made according to the antibiotic susceptibility pattern [ 37 ].…”

Section: Endocarditis In Patients With Prosthetic Heart Valves (Phv)mentioning

confidence: 99%

Bacteriophages for the Treatment of Graft Infections in Cardiovascular Medicine

et al. 2021

View full text Add to dashboard Cite

Bacterial infections of vascular grafts represent a major burden in cardiovascular medicine, which is related to an increase in morbidity and mortality. Different factors that are associated with this medical field such as patient frailty, biofilm formation, or immunosuppression negatively influence antibiotic treatment, inhibiting therapy success. Thus, further treatment strategies are required. Bacteriophage antibacterial properties were discovered 100 years ago, but the focus on antibiotics in Western medicine since the mid-20th century slowed the further development of bacteriophage therapy. Therefore, the experience and knowledge gained until then in bacteriophage mechanisms of action, handling, clinical uses, and limitations were largely lost. However, the parallel emergence of antimicrobial resistance and individualized medicine has provoked a radical reassessment of this approach and cardiovascular surgery is one area in which phages may play an important role to cope with this new scenario. In this context, bacteriophages might be applicable for both prophylactic and therapeutic use, serving as a stand-alone therapy or in combination with antibiotics. From another perspective, standardization of phage application is also required. The ideal surgical bacteriophage application method should be less invasive, enabling highly localized concentrations, and limiting bacteriophage distribution to the infection site during a prolonged time lapse. This review describes the latest reports of phage therapy in cardiovascular surgery and discusses options for their use in implant and vascular graft infections.

show abstract

Section: Endocarditis In Patients With Prosthetic Heart Valves (Phv)mentioning

confidence: 99%